Melanocortins as innovative drugs for ischemic diseases and neurodegenerative disorders: Established data and perspectives

Current Medicinal Chemistry

Volumn 20, Issue 6, 2013, Pages 735-750

  Leone, S ^a   Noera, G ^b,c   Bertolini, A ^d  

^a UNIVERSITY OF CHIETI   (Italy)

^b MARIA CECILIA HOSPITAL   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Alzheimer's disease; Amyotrophic lateral sclerosis; Heart ischemia reperfusion; Intestinal ischemia reperfusion; Ischemic diseases; Melanocortins; Miocardial infarction; Multiple sclerosis; Parkinson's disease; Renal ischemia; Respiratory arrest; Shock; Stroke

Indexed keywords

ALPHA INTERMEDIN; BETA INTERMEDIN; BL 30201; CORTICOTROPIN; CORTICOTROPIN[18-39]; GAMMA INTERMEDIN; HORMONE RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERMEDIN; MELANIN; MELANOCORTIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR AGONIST; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 4 RECEPTOR AGONIST; MELANOCORTIN 5 RECEPTOR; MELANOCORTIN RECEPTOR; MELANOCORTIN RECEPTOR AGONIST; MELANOTAN II; MITOGEN ACTIVATED PROTEIN KINASE; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; OPIATE; PEPTIDE DERIVATIVE; PHEOMELANIN; PIPECOLIC ACID; PROOPIOMELANOCORTIN; TETRACOSACTIDE ZINC PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO ACID SEQUENCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN ISCHEMIA; CELL PROLIFERATION; CYCLIZATION; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG POTENCY; HUMAN; INFLAMMATION; ISCHEMIA; MELANOMA CELL; MICROGLIA; NEURAL STEM CELL; NEUROTROPISM; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS;

EID: 84878003705     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867311320060001     Document Type: Article

References (310)

1. Baue, A.E. Multiple organ failure, multiple organ dysfunction syndrome, and systemic inflammatory response syndrome. Why no magic bullets? Arch. Surg., 1997, 132, 703-707. (Pubitemid 27305220)
2. Altavilla, D.; Saitta, A.; Squadrito, G.; Galeano, M.; Venuti, S.F.; Guarini, S.; Bazzani, C.; Bertolini, A.; Caputi, A.P.; Squadrito, F. Evidence for a role of nuclear factor-kappaB in acute hypovolemic hemorrhagic shock. Surgery, 2002, 131, 50-58. (Pubitemid 34118596)
3. Iadecola, C.; Anrather, J. The immunology of stroke: from mechanisms to translation. Nat. Med., 2011, 17, 796-808.
4. Arslan, F.; de Kleijn, D.P.; Pasterkamp, G. Innate immune signaling in cardiac ischemia. Nat. Rev. Cardiol., 2011, 8, 292-300.
5. Gottlieb, R.A. Cell death pathways in acute ischemia/reperfusion injury. J. Cardiovasc. Pharmacol. Ther., 2011, 16, 233-238.
6. Marchant, D.J.; Boyd, J.H.; Lin, D.C.; Granville, D.J.; Garmaroudi, F.S.; McManus, B.M. Inflammation in myocardial diseases. Circ. Res., 2012, 110, 126-144.
7. Glass, C.K.; Saijo, K.; Winner, B.; Marchetto, M.C.; Gage, F.H. Mechanisms underlying inflammation in neurodegeneration. Cell, 2010, 140, 918-934.
8. Amor, S.; Puentes, F.; Baker, D.; van der Valk, P. Inflammation in neurodegenerative diseases. Immunology., 2010, 129, 154-169.
9. Saijo, K.; Crotti, A.; Glass, C.K. Nuclear receptors, inflammation, and neurodegenerative diseases. Adv. Immunol., 2010, 106, 21-59.
10. Bertolini, A., Drug-induced activation of the nervous control of inflammation: A novel possibility for the treatment of hypoxic damage. Eur. J. Pharmacol., 2012, 679, 1-8.
11. Singh, A.; Haslach, E.M.; Haskell-Luevano, C. Structure-Activity relationships (SAR) of melanocortin and agouti-related (ARP) peptides. In Melanocortins: Multiple Actions and Therapeutic Potential. Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York; 2010; pp. 1-18.
12. Holder, J.R.; Haskell-Luevano, C. Melanocortin ligands: 30 years of structure-Activity relationship (SAR) studies. Med. Res. Rev., 2004, 24, 325-356. (Pubitemid 38490035)
13. Lipton, J.M.; Ceriani, G.; Macaluso, A.; McCoy, D.; Carnes, K.; Biltz, J.; Catania, A. Anti-inflammatory effects of the neuropeptide -MSH in acute, chronic and systemic inflammation. Ann. N.Y. Acad. Sci., 1994, 741, 137-148.
14. Catania, A.; Lonati, C.; Sordi, A.; Carlin, A.; Leonardi, P.; Gatti, S. The melanocortin system in control of inflammation. Scientific. World Journal., 2010, 10, 1840-1853.
15. Bertolini, A.; Tacchi, R.; Vergoni, A.V. Brain effects of melanocortins. Pharmacol. Res., 2009, 59, 13-47.
16. Mains, R.E.; Eipper, B.A.; Ling, N. Common precursor to corticotropins and endorphins. Proc. Natl. Acad. Sci. USA, 1977, 74, 3014-3018. (Pubitemid 8132482)
17. Roberts, J.L.; Herbert, E. Characterization of a common precursor to corticotropin and beta-lipotropin: identification of beta-lipotropin peptides and their arrangement relative to corticotropin in the precursor synthesized in a cellfree system. Proc. Natl. Acad. Sci. USA, 1977, 74, 5300-5304.
18. Nakanishi, S.; Inoue, A.; Kita, T.; Nakamura, M.; Chang, A.C.; Cohen, S.N.; Numa, S. Nucleotide sequence of cloned cDNA for bovine corticotropinbeta-lipotropin precursor. Nature, 1979, 278, 423-427. (Pubitemid 9130699)
19. Chang, A.C.; Cochet, M.; Cohen, S.N. Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide. Proc. Natl. Acad. Sci. USA, 1980, 77, 4890-4894. (Pubitemid 11236540)
20. Drouin, J.; Goodman, H.M. Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature, 1980, 288, 610-613. (Pubitemid 11223698)
21. Heining, J.A.; Keeley, F.W.; Robson, P.; Sower, S.A.; Youson, J.H. The appearance of proopiomelanocortin early in vertebrate evolution: cloning and sequencing of POMC from a Lamprey pituitary cDNA library. Gen. Comp. Endocrinol., 1995, 99, 137-144.
22. O'Donohue, T.L.; Dorsa, D.M. The opiomelanotropinergic neuronal and endocrine systems. Peptides., 1982, 3, 353-395. (Pubitemid 12022681)
23. De Wied, D.; Jolles, J. Neuropeptides derived from pro-opiocortin: behavioral, physiological, and neurochemical effects. Physiol. Rev., 1982, 62, 976-1059.
24. Eberle, A.N. The melanotropins: chemistry, physiology and mechanisms of action. Basel: Karger., 1988.
25. Hadley, M.E.; Haskell-Luevano, C. The proopiomelanocortin system. Ann. N.Y. Acad. Sci., 1999, 885, 1-21.
26. Blalock, J.E.; Costa, O. Immune neuroendocrine interactions: implications for reproductive physiology. Ann. N.Y. Acad. Sci., 1989, 564, 261-266. (Pubitemid 19231180)
27. Ferrari,W.; Floris, E.; Paulesu, F. Su di una particolare, imponente sintomatologia prodotta nel cane dall'ACTH iniettato nella cisterna magna. Boll. Soc. It. Biol. Sper., 1955, 31, 862-864.
28. Ferrari, W. Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone. Nature, 1958, 181, 925-926.
29. Ferrari, W.; Gessa, G.L.; Vargiu, L. Behavioral effects induced by intracisternally injected ACTH and MSH. Ann. N.Y. Acad. Sci., 1963, 104, 330-345.
30. De Wied, D. Effects of peptide hormones on behavior. In: Frontiers in neuroendocrinology; Ganong, W.F.; Martini, L., Ed.; Oxford University Press: London/New York, 1969; Vol. 1, pp. 97-140.
31. Bertolini, A.; Vergoni, W.; Gessa, G.L.; Ferrari, W. Induction of sexual excitement by the action of adrenocorticotrophic hormone in brain. Nature, 1969, 221, 667-669.
32. Bertolini, A.; Gessa, G.L. Behavioral effects of ACTH and MSH peptides. J. Endocrinol. Invest., 1981, 4, 241-251. (Pubitemid 11008804)
33. Ferrari, W.; Floris, E.; Paulesu, F. Eosinopenic effect of ACTH injected into the cisterna magna. Boll. Soc. It. Biol. Sper., 1955, 31, 859-862.
34. Bertolini, A.; Poggioli, R.; Vergoni, A.V. Cross-species comparison of the ACTH-induced behavioral syndrome. Ann. N.Y. Acad. Sci, 1988, 525, 114-129.
35. Dorr, R.T.; Lines, R.; Levine, N.; Brooks, C.; Xiang, L.; Hruby, V.J.; Hadley, M.E. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide in a pilot phase-I clinical study. Life Sci., 1996, 58, 1777-1784. (Pubitemid 26148611)
36. Gispen, W.H.; Wiegant, V.M.; Greven, H.M.; De Wied, D. The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-Activity study. Life Sci., 1975, 17, 645-652.
37. Gispen, W.H.; Isaacson, R.L. ACTH-induced excessive grooming in the rat. Pharmacol. Ther., 1981, 12, 209-46. (Pubitemid 11183307)
38. Bertolini, A.; Vergoni, W. Eccitazione sessuale nel coniglio da ACTH iniettato per via intraventricolare. Boll. Soc. It. Biol. Sper., 1968, 44, 954-956.
39. Bertolini, A.; Gessa, G.L.; Vergoni, W.; Ferrari, W. Induction of sexual excitement with intraventricular ACTH; permissive role of testosterone in themale rabbit. Life Sci., 1968, 7, 1203-1206.
40. Bertolini, A.; Gessa, G.L.; Ferrari, W. Penile erection and ejaculation: A central effect of ACTH-like peptides in mammals. In: Sexual behavior: pharmacology and biochemistry; Sandler M and Gessa GL Eds; New York: Raven Press; 1975. pp. 247-57.
41. Meyerson, B.J.; Bohus, B. Effect of ACTH4-10 on copulatory bahavior and on the response for socio-sexual motivation in the female rat. Pharmacol. Biochem. Behav., 1976, 5, 539-545. (Pubitemid 8034582)
42. Wilson, C.A.; Thody, A.J.; Everard, D. Effect of various ACTH analogs on lordosis behaviour in the female rat. Horm. Behav., 1979, 13, 293-300. (Pubitemid 10097936)
43. Shadiack, A.M.; Sharma, S.D.; Earle, D.C.; Spana, C.; Hallam, T.J. Melanocortins in the treatment of male and female sexual dysfunction. Curr. Top. Med. Chem., 2007, 7, 1137-1144. (Pubitemid 47044744)
44. Safarinejad, M.R. Evaluation of the safety and efficacy of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: A double-blind placebo-controlled, fixed dose, randomized study. J. Sex. Med., 2008, 5, 887-897. (Pubitemid 351472199)
45. Murphy, J.V.; Miller, R.E. The effect of adrenocorticotrophic hormone (ACTH) on avoidance conditioning in the rat. J. Comp. Physiol. Psychol., 1955, 48, 47-49.
46. Applezweig, M.H.; Baudry, F.D. The pituitary-Adrenocortical system in avoidance learning. Psychol. Rep., 1955, 1, 417-420.
47. Sandman, C.A.; Kastin, A.J.; Schally, A.V. Melanocyte-stimulating hormone and learned appetitive behavior. Experientia, 1969, 25, 1001-1002.
48. Flood, J.F.; Jarvik, M.E.; Bennett, E.L.; Orme, A.E. Effects of ACTH peptide fragments on memory formation. Pharmacol. Biochem. Behav., 1976, 5(Suppl 1), 41-51.
49. Stratton, L.O.; Kastin, A.J. Avoidance learning at two levels of shock in rats receiving MSH. Horm. Behav., 1974, 5, 149-155.
50. Isaacson, R.L.; Dunn, A.J.; Rees, H.D.; Waldock, B. ACTH 4-10 and improved use of information in rats. Physiol. Psychol., 1976, 4, 159-162.
51. Sandman, C.A.; George, J.M.; Nolan, J.D.; van Riezen, H.; Kastin, A.J. Enhancement of attention in man with ACTH/MSH 4-10. Physiol. Behav., 1975, 15, 427-431.
52. Van Riezen, H.; Rigter, H.; De Wied, D. Possible significance of ACTH fragments for human mental performance. Behav. Biol., 1977, 20, 311-324. (Pubitemid 8137112)
53. De Wied, D. Neuropeptides and behaviour. In: Discoveries in pharmacology: psycho-And neuro-pharmacology; Parnham MJ and Bruinvels J, Ed; 1. Elsevier Science Publishers BV; 1983, pp. 307-53.
54. Bertolini, A.; Poggioli, R.; Ferrari, W. ACTH-induced hyperalgesia in rats. Experientia, 1979, 35, 1216-1217. (Pubitemid 10219537)
55. Bertolini, A.; Poggioli, R.; Castelli, M.; Genedani, S. Effetto dell'ACTH-1-24 sulla sensibilitá algogena del ratto. Atti IV Congr. Naz. Soc. Med. Sperim. June 15-17, 1978. Riv. Farmacol. Ter., 1979, 10, 85.
56. Amir, S.; Amit, Z. The pituitary gland mediates acute and chronic pain responsiveness in stressed and non-stressed rats. Life Sci., 1979, 24, 439-448. (Pubitemid 9130137)
57. Sandman, C.A.; Kastin, A.J. Intraventricular administration of MSH induces hyperalgesia in rats. Peptides, 1981, 2, 231-233. (Pubitemid 11030849)
58. Williams, D.W.J.; Lipton, J.M.; Giesecke, A.H.J. Influence of centrally administered peptides on ear withdrawal from heat in the rabbit. Peptides, 1986, 7, 1095-1100. (Pubitemid 17226736)
59. Winter, C.A.; Flataker, L. The effect of cortisone, desoxycorticosterone, and adrenocorticotrophic hormone upon the responses of animals to analgesic drugs. J. Pharmacol. Exp. Ther., 1951, 103, 93-105.
60. Paroli, E. Indagini sull'effetto antimorfinico dell'ACTH. I. Relazioni con il corticosurrene e i livelli ematici degli 11-OH steroidi. Arch. It. Sci. Farmacol., 1967, 13, 234-237.
61. Gispen, W.H.; Buitelaar, J.; Wiegant, V.M.; Terenius, L.; De Wied, D. Interaction between ACTH fragments, brain opiate receptors and morphineinduced analgesia. Eur. J. Pharmacol., 1976, 39, 393-397.
62. Krivoy, W.A.; Kroeger, D.C.; Zimmermann, E. Neuropeptides: influence of acute and chronic effects of opiates. Psychoneuroendocrinology, 1977, 2, 43-51. (Pubitemid 8061122)
63. Fratta, W.; Bertolini, A.; Gessa, G.L. Interaction between ACTH and betaendorphin at the CNS level. Adv. Biosci., 1983, 44, 471-476.
64. Bertolini, A.; Poggioli, R.; Ferrari, W. Possible physiological role of ACTHpeptides in nociception. Adv. Biochem. Psychopharmacol., 1980, 22, 109-117.
65. Bertolini, A.; Ferrari, W. Evidence and implications of a melanocortins/endorphins homeostatic system. In: Neuropeptides and psychosomatic precesses; Endröczi E, Ed.; Budapest: Akadémiai Kiadó, 1981, pp. 245-261.
66. Wiegant, V.M.; Gispen, W.H.; Terenius, L., de Wied, D. ACTH-like peptides and morphine: interaction at the level of the CNS. Psychoneuroendocrinology, 1977, 2, 63-70.
67. Jacquet, Y.F. Opiate effects after adrenocorticotropin or beta-endorphin injection in the periaqueductal gray matter of rats. Science, 1978, 201, 1032-1034. (Pubitemid 9035538)
68. Fratta, W.; Rossetti, Z.L.; Poggioli, R.; Gessa, G.L. Reciprocal antagonism between ACTH1-24 and beta-endorphin in rats. Neurosci. Lett., 1981, 24, 71-74. (Pubitemid 11033327)
69. Bertolini, A.; Poggioli, R.; Vergoni, A.V.; Castelli, M.; Guarini, S. Evidence that melanocortins are physiological antagonists of opioids. In: De Wied, D.; Ferrari, W. Ed. Central actions of ACTH and related peptides. Berlin-Heidelberg: Springer-Verlag; 1986. pp. 207-222.
70. Zimmermann, E.; Krivoy, W. Antagonism between morphine and the polypeptides ACTH, ACTH1-24 and beta-MSH in the nervous system. Prog. Brain. Res., 1973, 39, 383-394.
71. Poggioli, R.; Castelli, M.; Genedani, S.; Bertolini, A. Influenza della morfina sulla sindrome comportamentale da ACTH. Riv. Farmacol. Ter., 1978, 9, 127-133. (Pubitemid 9082828)
72. Hendrie, C.A. Opiate dependence and withdrawal a new synthesis? Pharmacol. Biochem. Behav., 1985, 23, 863-870. (Pubitemid 16201088)
73. Vergoni, A.V.; Poggioli, R.; Bertolini, A. Corticotropin inhibits food intake in rats. Neuropeptides, 1986, 7, 153-158. (Pubitemid 16105025)
74. Poggioli, R.; Vergoni, A.V., Bertolini, A. ACTH-(1-24) and alpha-MSH antagonize feeding behavior stimulated by kappa opiate agonists. Peptides, 1986, 7, 843-848. (Pubitemid 17182352)
75. Strand, F.L.; Kung, T.T. ACTH accelerates recovery of neuromuscolar function following crushing of peripheral nerve. Peptides, 1980, 1, 135-138. (Pubitemid 11244070)
76. Bijlsma, W.A.; Jennekens, F.G.I.; Schotman, P.; Gispen, W.H. Effect of corticotrophin (ACTH) on recovery of sensorimotor function in the rat: structure-Activity study. Eur. J. Pharmacol., 1981, 76, 73-79. (Pubitemid 12252174)
77. Bijlsma, W.A.; van Asselt, E.; Veldman, H.; Jennekens, F.G.; Schotman, P.; Gispen, W.H. Ultrastructural study of effect of ACTH (4-10) on nerve regeneration; axons become larger in number and smaller in diameter. Acta Neuropathol., 1983, 62, 24-30. (Pubitemid 14247813)
78. Nyakas, C.; Veldhuis, H.D.; De Wied, D. Beneficial effect of chronic treatment with Org-2766 and -MSH on reversal learning of rats with bilateral lesions of the parafascicular area. Brain Res. Bull., 1985, 15, 257-265. (Pubitemid 16229704)
79. Isaacson, R.L.; Poplawsky, A. An ACTH(4-9) analog (Org-2766) speeds recovery from septal hyperemotionality in the rat. Behav. Neural. Biol., 1983, 39, 52-59. (Pubitemid 14215737)
80. Benelli, A.; Zanoli, P.; Botticelli, A.; Bertolini, A. [Nle4,D-Phe7]-MSH improves functional recovery in rats subjected to diencephalic hemisection. Eur. J. Pharmacol., 1988, 150, 211-219.
81. Bertolini, A.; Guarini, S.; Rompianesi, E.; Ferrari, W. Alpha-MSH and other ACTH fragments improve cardiovascular function and survival in experimental hemorrhagic shock. Eur. J. Pharmacol., 1986, 130, 19-26. (Pubitemid 17170848)
82. Bertolini, A.; Guarini, S.; Ferrari, W. Adrenal-independent, anti-shock effect of ACTH-(1-24) in rats. Eur. J. Pharmacol., 1986, 122, 387-388. (Pubitemid 16061490)
83. Guarini, S.; Bazzani, C.; Bertolini, A. Resuscitating effect of melanocortin peptides after prolonged respiratory arrest. Br. J. Pharmacol., 1997, 121, 1454-1460. (Pubitemid 27317560)
84. Chhajlani, V.; Wikberg, J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett., 1992, 309, 417-420.
85. Mountjoy, K.G.; Robbins, L.S.; Mortrud, M.T.; Cone, R.D. The cloning of a family of genes that encode the melanocortin receptors. Science, 1992, 257, 1248-1251.
86. Gantz, I.; Shimoto, Y.; Konda, Y.; Miwa, H.; Dickinson, C.J.; Yamada, T. Molecular cloning, expression, and characterization of a fifth melanocortin receptor. Biochem. Biophys. Res. Commun., 1994, 200, 1214-1222.
87. Chhajlani, V.; Muceniece, R.; Wikberg, J.E. Molecular cloning of a novel human melanocortin receptor. Biochem. Biophys. Res. Commun., 1993, 195, 866-873. (Pubitemid 23280496)
88. Tatro, J.B. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation, 1996, 3, 259-284. (Pubitemid 27230988)
89. Wikberg, J.E.; Muceniece, R.; Mandrika, I.; Prusis, P.; Lindblom, J.; Post, C.; Skottner, A. New aspects on the melanocortins and their receptors. Pharmacol. Res., 2000, 42, 393-420.
90. Schiöth, H.B. The physiological role of melanocortin receptors. Vitam. Horm., 2001, 63, 195-232. (Pubitemid 33805714)
91. Catania, A. The melanocortin system in leukocyte biology. J. Leukoc. Biol., 2007, 81, 383-392. (Pubitemid 46198388)
92. Eves, P.; Haycock, J.; Layton, C.; Wagner, M.; Kemp, H.; Szabo, M.; Morandini, R.; Ghanem, G.; Garcia-Borron, J.C.; Jimenez-Cervantes, C.; Mac Neil, S. Anti-inflammatory and anti-invasive effects of -melanocytestimulating hormone in human melanoma cells. Br. J. Cancer, 2003, 89, 2004-2015. (Pubitemid 37533283)
93. Konda, Y.; Gantz, I.; Del Valle, J.; Shimoto, Y.; Miwa, H.; Yamada, T. Interaction of dual intracellular signaling pathways activated by the melanocortin-3 receptor. J. Biol. Chem., 1994, 269, 13162-13166. (Pubitemid 24206079)
94. Eves, P.C.; Haycock, J.W. Melanocortin signalling mechanisms. In Melanocortins: Multiple Actions and Therapeutic Potential; Catania, A. Ed.; Landes Bioscience and Springer Science + Business Media, New York. 2010; pp. 19-28.
95. Buggy, J.J. Binding of -melanocyte-stimulating hormone to its G-proteincoupled receptor on B-lymphocytes activates the Jak/STAT pathway. Biochem. J., 1998, 331(Pt 1), 211-216. (Pubitemid 28163976)
96. Lasaga, M.; Debeljuk, L.; Durand, D.; Scimonelli, T.N.; Caruso, C. Role of -melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation. Peptides, 2008, 29, 1825-1835.
97. Mountjoy, K.G. Distribution and function of melanocortin receptors within the brain. In Melanocortins: Multiple Actions and Therapeutic Potential; Catania, A., Ed. Landes Bioscience and Springer Science + Business Media, New York. 2010; pp. 29-48.
98. Haskell-Luevano, C.; Sawyer, T.K.; Hendrata, S.; North, C.; Panahinia, L.; Stum, M.; Staples, D.J.; Castrucci, A.M.; Hadley, M.F.; Hruby, V.J. Truncation studies of alpha-melanotropin peptides identify tripeptide analogs exhibiting prolonged agonist bioactivity. Peptides, 1996, 17, 995-1002. (Pubitemid 26355326)
99. Hruby, V.J.; Wilkes, B.C.; Hadley, M.E.; Al-Obeidi, F.; Sawyer, T.K.; Staples, D.J.; de Vaux, A.E.; Dym, O.; Castrucci, A.M.; Hintz, M.F. et al. alpha-Melanotropin: the minimal active sequence in the frog skin bioassay. J. Med. Chem., 1987, 30, 2126-2130. (Pubitemid 18046075)
100. Castrucci, A.M.; Hadley, M.E.; Sawyer, T.K.; Wilkes, B.C.; al-Obeidi, F.; Staples, D.J.; de Vaux, A.E.; Dym, O.; Hintz, M.F.; Riehm, J.P.; et al. Alpha-melanotropin: the minimal active sequence in the lizard skin bioassay. Gen. Comp. Endocrinol., 1989, 73, 157-163. (Pubitemid 19032221)
101. Sahm, U.G.; Olivier, G.W.; Branch, S.K.; Moss, S.H.; Pouton, C.W. Synthesis and biological valuation of alpha-MSH analogs substituted with alanine. Peptides, 1994, 15, 1297-1302. (Pubitemid 24337087)
102. Sawyer, T.K.; Sanfilippo, P.J.; Hruby, V.J.; Engel, M.H.; Heward, C.B.; Burnett, J.B.; Hadley, M.E. 4-Norleucine, 7-D-phenylalanine-Alphamelanocyte- stimulating hormone: A highly potent alpha-melanotropin with ultralong biological activity. Proc. Natl. Acad. Sci. U S A., 1980, 77, 5754-5758. (Pubitemid 11206397)
103. Schiöth, H.B.; Muceniece, R.; Larsson M.; Mutulis, F.; Szardenings, M.; Prusis, P. et al. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur. J. Pharmacol., 1997, 319, 369-373. (Pubitemid 27056061)
104. Bednarek, M.A.; Mac Neil, T.; Tang, R.; Fong, T.M.; Cabello, M.A.; Maroto, M.; Teran, A: Potent and selective agonists of alpha-melanotropin (alphaMSH) action at human melanocortin receptor 5; linear analogs of alphamelanotropin. Peptides, 2007, 28, 1020-1028. (Pubitemid 46654443)
105. Holder, J.R.; Haskell-Luevano, C. Melanocortin tetrapeptides modified at the N-Terminus, His, Phe, Arg, and Trp positions. Ann. N.Y. Acad. Sci., 2003, 994, 36-48. (Pubitemid 36793848)
106. Fung, S.; Hruby, V.J. Design of cyclic and other templates for potent and selective peptide alpha-MSH analogs. Curr. Opin. Chem. Biol., 2005, 9, 352-358. (Pubitemid 41019680)
107. Qu, H.; Cai, M.; Mayorov, A.V.; Grieco, P.; Zingsheim, M.; Trivedi, D.; Hruby, V.J. Substitution of arginine with proline and proline derivatives in melanocyte-stimulating hormones leads to selectivity for human melanocortin 4 receptor. J. Med. Chem., 2009, 52, 3627-3635.
108. Hruby, V.J.; Lu, D.; Sharma, S.D.; Castrucci, A.L.; Kesterson, R.A.; al-Obeidi, F.A.; Hadley, M.E.; Cone, R.D. Cyclic lactam alpha-melanotropin analogs of Ac-Nle4-cyclo[Asp5, D-Phe7,Lys10] alpha-melanocytestimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J. Med. Chem., 1995, 38,, 3454-3461.
109. Schiöth, H.B.; Mutulis, F.; Muceniece, R.; Prusis, P.; Wikberg, J.E. Discovery of novel melanocortin 4 receptor selective MSH analogs. Br. J. Pharmacol., 1998, 124, 75-82. (Pubitemid 28210046)
110. Kask, A.; Mutulis, F.; Muceniece, R.; Pähkla, R.; Mutule, I.; Wikberg, J.E. et al. Discov ery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): evaluation in vitro and in vivo. Endocrinology, 1998, 139, 5006-5014. (Pubitemid 28533449)
111. Schiöth, H.B.; Muceniece, R.; Mutulis, F.; Bouifrouri, A.A.; Mutule, I.; Wikberg, J.E. Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119. Neuropeptides, 1999, 33, 191-196. (Pubitemid 29398139)
112. Skuladottir, G.V.; Jonsson, L.; Skarphedinsson, J.O.; Mutulis, F.; Muceniece, R.; Raine, A. Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br. J. Pharmacol., 1999, 126, 27-34. (Pubitemid 29041740)
113. Balse-Srinivasan, P.; Grieco, P.; Cai, M.; Trivedi, D.; Hruby VJ. Structureactivity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogs that lead to potent and selective ligands for the human MC3R and human MC5R. J. Med. Chem., 2003, 46, 3728-3733. (Pubitemid 36992207)
114. Hess, S.; Linde, Y.; Ovaia, O.; Safrai, E.; Shalev, D.E.; Swed, A.; Halbfinger, E.; Lapidot, T.; Winkler, I.; Gabinet, Y.; Faier, A.; Yarden, D.; Xiang, Z.; Portillo, F.P.; Haskell-Luevano, C.; Gilon, C.; Hoffman, A. Backbone cyclic peptidomimetic melanocortin-4 receptor agonist as a novel orally administrated drug lead for treating obesity. J. Med. Chem., 2008, 51, 1026-1034. (Pubitemid 351304710)
115. Linde, Y.; Ovaia, O.; Safrai, E.; Xiang, Z.; Portillo, F.P.; Shalev, D.E.; Haskell-Luevano, C.; Hoffman, A.; Gilon, C. Structure-Activity relationship and metabolic stability studies of backbone cyclization and N-methylation of melanocortin peptides. Biopolymers., 2008, 90, 671-682.
116. Yan, L.Z.; Hsiung, H.M.; Heiman, M.L.; Gadski, R.A.; Emmerson, P.J.; Hertel, J.; Flora, D.; Edwards, P.; Smiley, D.; Zhang, L.; Husain, S.; Kahl, S.D.; Di Marchi, R.D.; Mayer, J.P. Structure-Activity relationships of beta-MSH derived melanocortin-4 receptor peptide agonists. Curr. Top. Med. Chem., 2007, 7, 1052-1067. (Pubitemid 47040514)
117. Dmitrieva, V.G.; Povarova, O.V.; Skvortsova, V.I.; Limborska, S.A.; Myasoedov, N.F.; Dergunova, L.V. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell. Mol. Neurobiol., 2010, 30, 71-79.
118. Stavchansky, V.V.; Yuzhakov, V.V.; Botsina, A.Y.; Skvortsova, V.I.; Bondurko, L.N.; Tsyganova, M.G.; Limborska, S.A.; Myasoedov, N.F.; Dergunova, L.V. The effect of Semax and its C-end peptide PGP on the morphology and proliferative activity of rat brain cells during experimental ischemia: A pilot study. J. Mol. Neurosci., 2011, 45, 177-185.
119. Kaplan, A.Y.; Kochetova, A.G.; Nezavibathko, V.N.; Rjasina, T.V.; Ashmarin, I.P. Synthetic ACTH analog Semax displays nootropic-like activity in humans. Neurosci. Res. Commun., 1996, 19, 115-123. (Pubitemid 26372326)
120. Greven, H.M.; DeWied, D. Influence of peptides structurally related to ACTHand MSH on active avoidance behaviour in rats. A structure-Activity relationship study. Front. Horm. Res., 1977, 4, 140-152.
121. Pitsikas, N.; Spruijt, B.M.; Josephy, M.; Algeri, S.; Gispen, W.H. Effect of Org2766, an ACTH(4-9) analog, on recovery after bilateral transection of the fimbria fornix in the rat. Pharmacol. Biochem. Behav., 1991, 38(4), 931-934.
122. Spruijt, B.M. Effects of the ACTH4-9 analog Org2766 on brain plasticity: modulation of excitatory neurotransmission? Psychoneuroendocrinology, 1992, 17, 315-325.
123. Witter, A.; Greven, H.M.; De Wied, D. Correlation between structure, behavioral activity and rate of biotransformation of some ACTH4-9 analogs. J. Pharmacol. Exp. Ther., 1975, 193, 853-860.
124. Sebhat, I.K.; Martin, W.J.; Ye, Z.; Barakat, K.; Mosley, R.T.; Johnston, D.B. et al. Design and pharmacology of N-[(3R)-1,2,3,4-Tetrahydroisoquino linium-3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)-2-[4-cyclohexyl-4-(1H-1,2, 4-Triazol-1-ylmethyl)piperidin-1-yl]-2-xoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist. J. Med. Chem., 2002, 45, 4589-4593.
125. Tucci, F.C.; White, N.S.; Markison, S.; Joppa, M.; Tran, J.A.; Fleck, B.A. et al. Potent and orally active non-peptide antagonists of the human melanocortin-4 receptor based on a series of trans-2-disubstituted cyclohexyl piperazines. Bioorg. Med. Chem. Lett., 2005, 15, 4389-4395. (Pubitemid 41188024)
126. Pontillo, J.; Tran, J.A.; Markison, S.; Joppa, M.; Fleck, B.A.; Marinkovic, D. et al. A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice. Bioorg. Med. Chem. Lett., 2005, 15, 2541-2566.
127. Ye, Z.; Guo, L.; Barakat, K.J.; Pollard, P.G.; Palucki, B.L.; Sebhat, I.K. et al. Discovery and activity of (1R,4S,6R)-N-[(1R)-2-[4-cyclohexyl-4-[[(1, 1-dimethylethyl)amino]carbonyl]-1-piperidinyl]-1-[(4-fluorophenyl)methyl] -2-oxoethyl]-2-methyl-2-Azabicyclo[2.2.2]octane-6-carboxamide (3, RY764), a potent and selective melanocortin subtype-4receptor agonist. Bioorg. Med. Chem. Lett., 2005, 15, 3501-3505. (Pubitemid 40942042)
128. Schlag, G.; Redl, H.; Hallström, S. The cell in shock: the origin of multiple organ failure. Resuscitation, 1991, 1, 137-180.
129. Jin, R.; Yang, G.; Li, G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J. Leukoc. Biol., 2010, 87, 779-789.
130. Baeuerle, P.A.; Henkel, T. Function and activation of NF-kappa B in the immune system. Annu. Rev. Immunol., 1994, 12, 141-179.
131. May, M.J.; Ghosh, S. Signal transduction through NF-kappa B. Immunol. Today., 1998, 19, 80-88.
132. Huang, J.; Upadhyay, U.M.; Tamargo, R.J. Inflammation in stroke and focal cerebral ischemia. Surg. Neurol., 2006, 66, 232-245. (Pubitemid 44279808)
133. Durukan, A.; Tatlisumak, T. Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol. Biochem. Behav., 2007, 87, 179-197. (Pubitemid 46860315)
134. Ghosh, S.; May, M.J.; Kopp, E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol., 1998, 16, 225-260. (Pubitemid 28183365)
135. Cuzzocrea, S.; Riley, D.P.; Caputi, A.P.; Salvemini, D. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev., 2001, 53, 135-159. (Pubitemid 32173112)
136. Iadecola, C.; Alexander, M. Cerebral ischemia and inflammation. Curr. Opin. Neurol., 2001, 14, 89-94. (Pubitemid 32116263)
137. Nedergaard, M.; Dirnagl, U. Role of glial cells in cerebral ischemia. Glia, 2005, 50, 281-286. (Pubitemid 40780834)
138. Rohnert, P.; Schmidt, W.; Emmerlich, P.; Goihl, A.; Wrenger, S.; Bank, U.; Nordhoff, K.; Tager, M.; Ansorge, S.; Reinhold, D.; Striggow, F. Dipeptidil peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia. Journal of Neuroinflammation, 2012, 9, 44-91
139. Zingarelli, B.; Squadrito, F.; Altavilla, D.; Calapai, G.; Di Rosa, M.; Caputi, A.P. Role of tumor necrosis factor-Alpha in acute hypovolemic hemorrhagic shock in rats. Am. J. Physiol., 1994, 266(4 Pt 2): H1512-1515.
140. Altavilla, D.; Cainazzo, M.M.; Squadrito, F.; Guarini, S.; Bertolini, A.; Bazzani, C. Tumour necrosis factor-Alpha as a target of melanocortins in haemorrhagic shock, in the anaesthetized rat. Br. J. Pharmacol., 1998, 124, 1587-1590. (Pubitemid 28377088)
141. Squadrito, F.; Altavilla, D.; Canale, P.; Ioculano, M.; Campo, G.M.; Ammendolia, L.; Ferlito, M.; Zingarelli, B.; Squadrito, G.; Saitta, A.; Caputi A.P. Participation of tumour necrosis factor and nitric oxide in the mediation of vascular dysfunction in splanchnic artery occlusion shock. Br. J. Pharmacol., 1994, 113, 1153-1158 (Pubitemid 24364392)
142. Foucart, S.; Abadie, C. Interleukin-1 beta and tumor necrosis factor-Alpha inhibit the release of [3H]-noradrenaline from mice isolated atria. Naunyn Schmiedebergs Arch. Pharmacol., 1996, 354, 1-6. (Pubitemid 26228452)
143. Murray, D.R.; Freeman, G.L. Tumor necrosis factor-Alpha induces a biphasic effect on myocardial contractility in conscious dogs. Circ. Res., 1996, 78, 154-160. (Pubitemid 26004132)
144. Szabó, C.; Thiemermann, C. Invited opinion: role of nitric oxide in hemorrhagic, traumatic, and anaphylactic shock and thermal injury. Shock, 1994, 2, 145-155.
145. Zingarelli, B.; Squadrito, F.; Altavilla, D.; Calapai, G.; Campo, G.; Caló, M.; Saitta, A.; Caputi, A.P. Evidence for a role of nitric oxide in hypovolemic hemorrhagic shock. J Cardiovasc. Pharmacol., 1992, 19, 982-986.
146. Thiemermann, C.; Szabó, C.; Mitchell. J.; Vane, J. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide. Proc. Natl. Acad. Sci. USA., 1993, 90, 267-271. (Pubitemid 23010291)
147. Brough, D.; Tyrrell, P.J.; Allan, S.M. Regulation of interleukin-1 in acute brain injury. Trends Pharmacol. Sci., 2011, 32, 617-622.
148. Emsley, H.C.; Smith, C.J.; Georgiou, R.F.; Vail, A.; Hopkins, S.J.; Rothwell, N.J.; Tyrrell, P.J. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J. Neurol. Neurosurg. Psychiatry, 2005, 76, 1366-1372. (Pubitemid 41360973)
149. Boutin, H.; Le Feuvre R.A.; Horai, R.; Asano, M.; Iwakura, Y.; Rothwell, N.J. Role of IL-1alpha and IL-1beta in ischemic brain damage. J. Neurosci., 2001, 21, 5528-5534. (Pubitemid 32692151)
150. Barone, F.C.; Feuerstein, G.Z. Inflammatory mediators and stroke: new opportunities for novel therapeutics. Cereb. Blood. Flow. Metab., 1999, 19, 819-934.
151. Block, M.L.; Zecca L.; Hong, J.S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci., 2007, 8, 57-69. (Pubitemid 46011999)
152. Hanisch, U.K. Microglia as a source and target of cytokines. Glia, 2002, 40, 140-155.
153. Nakajima, K.; Yamamoto, S.; Kohsaka, S.; Kurihara, T. Neuronal stimulation leading to upregulation of glutamate transporter-1 (GLT-1) in rat microglia in vitro. Neurosci. Lett., 2008, 436, 331-334.
154. Stoll. G.; Jander, S. The role of microglia and macrophages in the pathophysiology of the CNS. Prog. Neurobiol., 1999, 58, 233-247. (Pubitemid 29193056)
155. Thored, P.; Heldmann, U.; Gomes-Leal, W.; Gisler, R.; Darsalia, V.; Taneera J.; Nygren, J.M.; Jacobsen, S.E.; Ekdahl, C.T.; Kokaia, Z., Lindvall, O. Long-Term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke. Glia, 2009, 57, 835-849.
156. Lu, Y.Z.; Lin, C.H.; Cheng, F.C.; Hsueh, C.M. Molecular mechanisms responsible for microglia-derived protection of Sprague-Dawley rat brain cells during in vitro ischemia. Neurosci. Lett., 2005, 373, 159-164.
157. Batchelor, P.E.; Liberatore, G.T.; Wong, J.Y.; Porritt, M.J.; Frerichs, F.; Donnan, G.A.; Howells, D.W. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J. Neurosci., 1999, 19, 1708-1716. (Pubitemid 29094189)
158. David, S.; Kroner, A. Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci., 2011, 12,388-399.
159. Phani, S.; Loike, J.D.; Przedborski, S. Neurodegeneration and Inflammation in Parkinson's disease. Parkinsonism Relat. Disord., 2012, 18, Suppl 1:S207-9.
160. Gonzales, P.V.; Schiöth, H.B.; Lasaga, M.; Scimonelli, T.N. Memory impairment induced by IL-1beta is reversed by alpha-MSH through central melanocortin-4 receptors. Brain Behav. Immun., 2009, 23, 817-822.
161. Davalos, D.; Grutzendler, J.; Yang, G.; Kim, J.V.; Zuo, Y.; Jung, S.; Littman, D.R.; Dustin, M.L.; Gan, W.B. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 2005, 8, 752-758. (Pubitemid 43085841)
162. Yenari, M.A.; Kauppinen, T.M.; Swanson, R.A. Microglial activation in stroke: therapeutic targets. Neurotherapeutics, 2010, 7, 378-391.
163. Akiyama, H.; Barger, S.; Barnum, S.; Bradt, B.; Bauer, J.; Cole, G.M.; Cooper, N.R.; Eikelenboom, P.; Emmerling, M.; Fiebich, B.L., et al. Inflammation and Alzheimer's disease. Neurobiol. Aging., 2000, 21, 383-421. (Pubitemid 30349107)
164. Kitazawa, M.; Yamasaki, T.R.; LaFerla, F.M. Microglia as a potential bridge between the amyloid beta-peptide and tau. Ann. N.Y. Acad. Sci., 2004, 1035, 85-103. (Pubitemid 40362328)
165. Simi, A.; Tsakiri, N.; Wang, P.; Rothwell, N.J. Interleukin-1 and inflammatory neurodegeneration. Biochem. Soc. Trans., 2007, 35,1122-1126. (Pubitemid 350206443)
166. McCoy, M.K.; Tansey, M.G. TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease. J. Neuroinflammation, 2008, 17, 45.
167. Landreth, G.E.; Reed-Geaghan, E.G. Toll-like receptors in Alzheimer's disease. Curr. Top. Microbiol. Immunol., 2009, 336, 137-153.
168. Walter, S.; Letiembre, M.; Liu, Y.; Heine, H.; Penke, B.; Hao, W.; Bode, B., Manietta, N.; Walter, J.; Schulz-Schuffer, W. et al. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem., 2007, 20, 947-956. (Pubitemid 350059737)
169. Reed-Geaghan, E.G.; Savage, J.C.; Hise, A.G.; Landreth, G.E. CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J. Neurosci., 2009, 29, 11982-11992.
170. Stewart, C.R.; Stuart, L.M.; Wilkinson, K.; van Gils, J.M.; Deng, J.; Halle, A.; Rayner, K.J.; Boyer, L.; Zhong, R.; Frazier, W.A. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat. Immunol., 2009, 11, 155-161.
171. Yan, S.D.; Chen, X.; Fu, J.; Chen, M.; Zhu, H.; Roher, A.; Slattery, T.; Zhao, L.; Nagashima, M.; Morser, J. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature, 1996, 382, 685-691. (Pubitemid 26282167)
172. Ramasamy, R.; Yan, S.F.; Schmidt, A.M. RAGE: therapeutic target and biomarker of the inflammatory response the evidence mounts. J. Leukoc. Biol., 2009, 86, 505-512.
173. Halle, A.; Hornung, V.; Petzold, G.C.; Stewart, C.R.; Monks, B.G.; Reinheckel, T.; Fitzgerald, K.A.; Latz, E.; Moore, K.J.; Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol., 2008, 9, 857-865.
174. Braak, H.; Del Tredici, K.; Rub, U.; de Vos, R.A.; Jansen Steur, E.N.,; Braak, E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging, 2003, 24, 197-211. (Pubitemid 36007810)
175. McGeer, P.L.; McGeer, E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve, 2002, 26, 459-470.
176. Vargas, M.R.; Pehar, M.; Diaz-Amarilla, P.J.; Beckman, J.S.; Barbeito, L. Transcriptional profile of primary astrocytes expressing ALS-linked mutant SOD1. J. Neurosci. Res., 2008, 86, 3515-3525.
177. Lassmann, S.; Kincaid, C.; Asensio, V.C.; Campbell, I.L. Induction of type 1 immune pathology in the brain following immunization without central nervous system autoantigen in transgenic mice with astrocyte-Targeted expression of IL-12. J. Immunol., 2001, 167, 5485-5493. (Pubitemid 33009791)
178. Frohman, E.M.; Racke, M.K.; Raine, C.S. Multiple sclerosis-The plaque and its pathogenesis. N. Engl. J. Med., 2006, 354, 942-955.
179. Trapp, B.D.; Nave, K.A. Multiple sclerosis: An immune or neurodegenerative disorder? Annu. Rev. Neurosci., 2008, 31, 247-269.
180. Korn, T.; Bettelli, E.; Oukka, M.; Kuchroo, V.K. IL-17 and Th17 Cells. Annu. Rev. Immunol., 2009, 27, 485-517.
181. Lipton, J.M.; Zhao, H.; Ichiyama, T.; Barsh, G.S.; Catania, A. Mechanisms of anti-inflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann. N.Y. Acad. Sci., 1999, 885, 173-182.
182. Lipton, J.M.; Catania, A. Anti-inflammatory actions of the neuroimmunomodulator -MSH. Immunol. Today, 1997, 18, 140-145.
183. Catania, A.; Gatti, S.; Colombo, G.; Lipton, J.M. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev., 2004, 56, 1-29. (Pubitemid 38314578)
184. Getting, S.J.; Perretti, M. MC3-R as a novel target for antiinflammatory therapy. Drug News Perspect., 2000, 13, 19-27. (Pubitemid 30261739)
185. Getting, S.J.; Allcock, G.H.; Flower, R.; Perretti, M. Natural and synthetic agonists of the melanocortin receptor type 3 possess anti-inflammatory properties. J. Leukoc. Biol., 2001, 69, 98-104. (Pubitemid 32095123)
186. Star, R.A.; Rajora, N.; Huang, J.; Stock, R.C.; Catania, A.; Lipton, J.M. Evidence of autocrine modulation of macrophage nitric oxide synthase by -melanocyte-stimulating hormone. Proc. Natl. Acad. Sci. USA., 1995, 92, 8016-8020.
187. Herraiz, C.; Jimenez-Cervantes, C.; Zanna, P.; Garcia-Borron, J.C. Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-Activated protein kinase pathways. FEBS Lett., 2009, 583, 3269-3274.
188. Chai, B.; Li, J.Y.; Zhang, W.; Ammori, J.B.; Mulholland, M.W. Melanocortin-3 receptor activates MAP kinase via PI3 kinase. Regul. Pept., 2007, 139, 115-121. (Pubitemid 46216486)
189. Rodrigues, A.R.; Pignatelli, D.; Almeida, H.; Gouveia, A.M. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Mol. Cell. Endocrinol., 2009, 303, 74-81.
190. Lee, D.J.; Biros, D.J.; Taylor, A.W. Injection of an -melanocyte stimulating hormone expression plasmid is effective in suppressing experimental autoimmune uveitis. Int. Immunopharmacol., 2009, 9, 1079-1086.
191. de Angelis, E.; Sahm, U.G.; Ahmed, A.R.; Olivier, G.W.; Notarianni, L.J.; Branch, S.K.; et al. Identification of a melanocortin receptor expressed by murine brain microvascular endothelial cells in culture. Microvasc. Res., 1995, 50, 25-34.
192. Catania, A.; Rajora, N.; Capsoni, F.; Minonzio, F.; Star, R.A.; Lipton, J.M. The neuropeptide alpha-MSHhas specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides, 1996, 17, 675-679. (Pubitemid 26238403)
193. Rajora, N.; Ceriani, G.; Catania, A.; Star, R.A.; Murphy, M.T.; Lipton, J.M. alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line. J. Leukoc. Biol., 1996, 59, 248-253. (Pubitemid 26098709)
194. Hartmeyer, M.; Scholzen, T.; Becher, E.; Bhardwaj, R.S.; Schwarz, T.; Luger, T.A. Human dermal microvascular endothelial cells express the melanocortin receptor type 1 and produce increased levels of IL-8 upon stimulation with alpha-melanocyte-stimulating hormone. J. Immunol., 1997, 159, 1930-1937. (Pubitemid 127484182)
195. Artuc, M.; Grützkau, A.; Luger, T.; Henz, B.M. Expression of MC1-And MC5-receptors on the human mast cell line HMC-1. Ann. N.Y. Acad. Sci., 1999, 885, 364-367.
196. Becher, E.; Mahnke, K.; Brzoska, T.; Kalden, D.H.; Grabbe, S.; Luger, T.A. Human peripheral blood-derived dendritic cells express functional melanocortin receptor MC-1R. Ann. N.Y. Acad. Sci., 1999, 885, 188-195.
197. Böhm, M.; Metze, D.; Schulte, U.; Becher, E.; Luger, T.A.; Brzoska, T. Detection of melanocortin-1 receptor antigenicity on human skin cells in culture and in situ. Exp. Dermatol., 1999, 8, 453-461.
198. Chakraborty, A.K.; Funasaka, Y.; Pawelek, J.M.; Nagahama, M.; Ito, A.; Ichihashi, M. Enhanced expression of melanocortin-1 receptor (MC1-R) in normal human keratinocytes during differentiation: evidence for increased expression of POMC peptides near suprabasal layer of epidermis. J. Invest. Dermatol., 1999, 112, 853-860. (Pubitemid 29277983)
199. Luger, T.A.; Brzoska, T.; Scholzen, T.E.; Kalden, D.H.; Sunderkötter, C.; Armstrong, C.; et al. The role of alpha-MSH as amodulator of cutaneous inflammation. Ann. N.Y. Acad. Sci., 2000, 917, 232-238.
200. Scott, M.C.; Suzuki, I.; Abdel-Malek, Z.A. Regulation of the human melanocortin 1 receptor expression in epidermal melanocytes by paracrine and endocrine factors and by ultraviolet radiation. Pigment. Cell. Res., 2002, 15, 433-439. (Pubitemid 35374625)
201. Bhardwaj, R.; Becher, E.; Mahnke, K.; Hartmeyer, M.; Schwarz, T.; Scholzen, T.; et al. Evidence for the differential expression of the functional alphamelanocyte-stimulating hormone receptor MC-1 on human monocytes. J. Immunol.,1997, 158, 3378-3384. (Pubitemid 127484057)
202. Manna, S.K.; Aggarwal, B.B. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J. Immunol., 1998, 161, 2873-2880. (Pubitemid 28425709)
203. Cooper, A.; Robinson, S.J.; Pickard, C.; Jackson, C.L.; Friedmann, P.S.; Healy, E. -Melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status. J. Immunol., 2005, 175, 4806-4813 (Pubitemid 41362024)
204. Rennalls, L.P.; Seidl, T.; Larkin, J.M.; Wellbrock, C.; Gore, M.E.; Eisen, T.; Bruno, L. The melanocortin receptor agonist NDP-MSH impairs the allostimulatory function of dendritic cells. Immunology, 2010, 129, 610-619.
205. Catania, A. Neuroprotective actions of melanocortins: A therapeutic opportunity. Trends Neurosci., 2008, 31, 353-360.
206. Delgado, R.; Carlin, A.; Airaghi, L.; Demitri, M.T.; Meda, L.; Galimberti, D.; Baron, P.; Lipton, J.M.; Catania, A. Melanocortin peptides inhibit production of proinflammatory cytokines and nitric oxide by activated microglia. J. Leukoc. Biol., 1998, 63, 740-745. (Pubitemid 28274836)
207. Galimberti, D.; Baron, P.; Meda, L.; Prat, E.; Scarpini, E.; Delgado, R.; Catania, A.; Lipton, J.M.; Scarlato, G. -MSH peptides inhibit production of nitric oxide and tumor necrosis factor-by microglial cells activated with -Amyloid and interferon Biochem. Biophys. Res. Commun., 1999, 263, 251256.
208. Caruso, C.; Durand, D.; Schioth, H.B.; Rey, R.; Seilicovich, A.; Lasaga, M. Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-in astrocytes. Endocrinology, 2007, 148, 4918-4926. (Pubitemid 47481532)
209. Teare, K.A.; Pearson, R.G.; Shakesheff, K.M.; Haycock, J.W. Alpha-MSH inhibits inflammatory signalling in Schwann cells. Neuroreport., 2004, 15, 493-498. (Pubitemid 38328147)
210. Guarini, S.; Cainazzo, M.M.; Giuliani, D.; Mioni, C.; Altavilla, D.; Marini, H.; Bigiani, A.; Ghiaroni, V.; Passaniti, M.; Leone, S.; Bazzani, C.; Caputi, A.P.; Squadrito, F.; Bertolini, A. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal antiinflammatory pathway. Cardiovasc. Res., 2004, 63, 357-365. (Pubitemid 38900850)
211. Borovikova, L.V.; Ivanova, S.; Zhang, M.; Yang, H.; Botchkina, G.I.; Watkins, L.R.; Wang, H.; Abumrad, N.; Eaton, J.W.; Tracey, K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature, 2000, 405, 458-462. (Pubitemid 30367422)
212. Tracey, K.J. The inflammatory reflex. Nature, 2002, 420, 853-859. (Pubitemid 36019638)
213. Tracey, K.J. Physiology and immunology of the cholinergic antiinflammatory pathway. J. Clin. Invest., 2007, 117, 289-296. (Pubitemid 46203953)
214. Mioni, C.; Bazzani, C.; Giuliani, D.; Altavilla, D.; Leone, S.; Ferrari, A.; Minutoli, L.; Bitto, A.; Marini, H.; Zaffe, D.; Botticelli, A.R.; Iannone, A.; Tomasi, A.; Bigiani, A.; Bertolini, A.; Squadrito, F.; Guarini, S. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit. Care Med., 2005, 33, 2621-2628. (Pubitemid 41682117)
215. Bertolini, A.; Guarini, S.; Ferrari, W.; Rompianesi, E. Adrenocorticotropin reversal of experimental hemorrhagic shock is antagonized by morphine. Life Sci., 1986, 39, 1271-1280. (Pubitemid 16004209)
216. Bertolini, A. Pharmaceutical compositions containing ACTH fragments for the therapy of shock conditions and for respiratory and cardiocirculatory insufficiencies. U.S. Patent 4, 794,104, Dicember 27, 1988,.
217. Bertolini, A.; Ferrari, W.; Guarini, S. The adrenocorticotropic hormone (ACTH)-induced reversal of hemorrhagic shock. Resuscitation, 1989, 18, 253-267. (Pubitemid 19285612)
218. Ludbrook, J.; Ventura, S. ACTH-(1-24) blocks the decompensatory phase of the haemodynamic response to acute hypovolaemia in conscious rabbits. Eur. J. Pharmacol., 1995, 275, 267-275.
219. Squadrito, F.; Guarini, S.; Altavilla, D.; Squadrito, G.; Campo, G.M.; Arlotta, M. Adrenocorticotropin reverses vascular dysfunction and protects against splanchnic artery occlusion shock. Br. J. Pharmacol., 1999, 128, 816-822. (Pubitemid 29504778)
220. Noera, G.; Lamarra, M.; Guarini, S.; Bertolini, A. Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24). Lancet, 2001, 358, 469-470. (Pubitemid 32769856)
221. Noera, G.; Lamarra, M.; Guarini, S.; Bazzani, C.; Leone, S.; Bertolini, A. Early treatment with ACTH(1-24) in haemorrhagic shock in humans: further data. Abstracts 32 Congr Naz Soc It Farm. Napoli: Minerva Medica, 2005:91.
222. Altavilla, D.; Bazzani, C.; Squadrito, F.; Cainazzo, M.M.; Mioni, C.; Bertolini, A. Adrenocorticotropin inhibits nitric oxide synthase II mRNA expression in rat macrophages. Life Sci, 2000, 66, 2247-2254. (Pubitemid 30256624)
223. Guarini, S.; Bazzani, C.; Cainazzo, M.M.; Mioni, C.; Ferrazza, G.; Vergoni, A.V. Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides. J. Pharmacol. Exp. Ther., 1999, 291, 1023-1027.
224. Bertolini, A. The opioid/anti-opioid balance in shock: A new target for therapy in resuscitation. Resuscitation, 1995, 30, 29-42.
225. Elam, R.; Bergmann, F.; Feuerstein, G. Simultaneous changes of catecholamines and of Leu-enkephalin-like immunoreactivity in plasma and cerebrospinal fluid of cats undergoing acute hemorrhage. Brain. Res., 1984, 303, 313-307
226. Bernton, E.W.; Long J.B.; Holaday, J.W. Opioids and neuropeptides: mechanisms in circulatory shock. Fed. Proc., 1985, 44, 290-299. (Pubitemid 15173205)
227. Chernow, B.; Lake, C.R.; Teich, S.; Mougey, E.H.; Meyerhoff, J., Casey, L.C. Hemorrhagic hypotension increases plasma beta-endorphin concentrations in the nonhuman primate. Crit. Care Med., 1986, 14, 505-507. (Pubitemid 16081369)
228. Schadt, JC. Sympathetic and hemodynamic adjustments to hemorrhage: A possible role for endogenous opioid peptides. Resuscitation, 1989, 18, 219-228. (Pubitemid 19285609)
229. Carmignani, M.; Zucchetti, F.; Sacco, R.; Bolognini, S.; Volpe, A.R. Shock induction by arterial hypoperfusion of the gut involves synergistic interactions between the peripheral enkephalin and nitric oxide systems. Int. J. Immunopathol. Pharmacol., 2005,18, 33-48. (Pubitemid 40343457)
230. Huh, S.K.; Lipton, J.M.; Batjer, H.H. The protective effects of alphamelanocyte-stimulating hormone on canine brain stem ischemia. Neurosurgery, 1997, 40, 132-139.
231. Forslin Aronsson, A.; Spulber, S.; Popescu, L.M.; Winblad, B.; Post, C.; Oprica, M.; Schultzberg, M. Alpha-melanocyte-stimulaing hormone is neuroprotective in rat global cerebral ischemia. Neuropeptides, 2006, 40, 65-75. (Pubitemid 43255414)
232. Giuliani, D.; Mioni, C.; Altavilla, D.; Leone, S.; Bazzani, C.; Minutoli, L.; Bitto, A.; Cainazzo, M.M.; Marini, H.; Zaffe, D.; Botticelli, A.R.; Pizzala, R.; Savio, M.; Necchi, D.; Schiöth, H.B.; Bertolini, A.; Squadrito, F.; Guarini, S. Both early and delayed treatment with melanocortin 4 receptorstimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology, 2006, 147, 1126-1135. (Pubitemid 43244343)
233. Bashkatova, V.G.; Koshelev, V.B.; Fadyukova, O.E.; Alexeev, A.A.; Vanin, A.F.; Rayevsky, K.S.; Ashmarin, I.P.; Armstrong, D.M. Novel synthetic analog of ACTH 4-10 (Semax) but not glycine prevents the enhanced nitric oxide generation in cerebral cortex of rats with incomplete global ischemia. Brain Res., 2001, 894, 145-149. (Pubitemid 32197608)
234. Bazzani, C.; Guarini, S.; Botticelli, A.R.; Zaffe, D.; Tomasi, A.; Bini, A.; Cainazzo, M.M.; Ferrazza, G.; Mioni, C.; Bertolini, A. Protective effect of melanocortin peptides in rat myocardial ischemia. J. Pharmacol. Exp. Ther., 2001, 297, 1082-1087. (Pubitemid 32472507)
235. Hassoun, H.T.; Zou, L.; Moore, F.A.; Kozar, R.A.; Weisbrodt, N.W.; Kone, B.C. Alpha-melanocyte-stimulating hormone protects against mesenteric ischemia-reperfusion injury. Am. J. Physiol. Gastrointest. Liver. Physiol., 2002, 282, G1059-1068. (Pubitemid 34651613)
236. Chiao, H.; Kohda, Y.; McLeroy, P.; Craig, L.; Housini, I.; Star, R.A. -Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J. Clin. Invest., 1997, 99, 1165-1172. (Pubitemid 27142751)
237. Jo, S.K.; Yun, S.Y.; Chang, K.H.; Cha, D.R.; Cho,W.Y.; Kim, H.K.; Won, N.H. -MSH decreases apoptosis in ischaemic acute renal failure in rats: possible mechanism of this beneficial effect. Nephrol. Dial. Transplant., 2001, 16, 1583-1591. (Pubitemid 32750449)
238. Simmons, M.N.; Subramanian, V.; Crouzet, S.; Haber, G.P. Colombo, J.R.; Jr., Ukimura, O.; Nielsen, S.; Gill, I.S. -Melanocyte stimulating hormone analog AP214 protects against ischemia induced acute kidney injury in a porcine surgical model. J. Urol., 2010, 183, 1625-1629.
239. Gatti, S.; Colombo, G.; Buffa, R.; Turcatti, F.; Garofalo, L.; Carboni, N. Alpha-melanocyte-stimulating hormone protects the allograft in experimental heart transplantation. Transplantation, 2002, 74, 1678-1684. (Pubitemid 36019317)
240. Edwards, P.M.; Kuiters, R.R.; Boer, G.J.; Gispen, W.H. Recovery from peripheral nerve transection is accelerated by local application of alpha-MSH by means of microporous Accurel polypropylene tubes. J. Neurol. Sci. Jul., 1986, 74,171-176. (Pubitemid 16097143)
241. Dekker, A.J. Effect of alpha-melanocyte-stimulating hormone on peripheral nerve regeneration in the rat: histological aspects and comparison with the effect of gangliosides. Exp. Neurol., 1988, 99, 490-497. (Pubitemid 18054745)
242. Van der Zee, C.E.; Brakkee, J.H.; Gispen, W.H. alpha-MSH and Org. 2766 in peripheral nerve regeneration: different routes of delivery. Eur. J. Pharmacol., 1988, 147, 351-357. (Pubitemid 18076495)
243. Laquerriere, A.; Peulve, P.; Jin, O.; Tiollier, J.; Tardy, M.; Vaudry, H.; et al. Effect of basic fibroblast growth factor and alpha-melanocytic stimulating hormone on nerve regeneration through a collagen channel. Microsurgery, 1994, 15, 203-210. (Pubitemid 24153068)
244. Plantinga, L.C.; Verhaagen, J.; Edwards, P.M.; Hali, M.; Brakkee, J.H.; Gispen, W.H. Pharmacological evidence for the involvement of endogenous alpha-MSH-like peptides in peripheral nerve regeneration. Peptides, 1995, 16, 319-324.
245. Van de Meent, H.; Hamers, F.P.; Lankhorst, A.J.; Joosten, E.A.; Gispen, W.H. Beneficial effects of the melanocortin alpha-melanocyte-stimulating hormone on clinical and neurophysiological recovery after experimental spinal cord injury. Neurosurgery, 1997, 40, 122-130.
246. Joosten, E.A.; Majewska, B.; Houweling, D.A.; Bär, P.R.; Gispen, W.H. Alpha-melanocyte stimulating hormone promotes regrowth of injured axons in the adult rat spinal cord. J. Neurotrauma, 1999, 16, 543-553. (Pubitemid 29297908)
247. Lankhorst, A.J.; Duis, S.E.; ter Laak, M.P.; Joosten, E.A.; Hamers, F.P.; Gispen, W.H. Functional recovery after central infusion of alphamelanocyte- stimulating hormone in rats with spinal cord contusion injury. J. Neurotrauma, 1999, 16, 323-331. (Pubitemid 29200825)
248. Van der Neut, R.; Bär, P.R.; Sodaar, P.; Gispen, W.H. Trophic influences of alpha-MSH and ACTH4-10 on neuronal outgrowth in vitro. Peptides, 1988, 9, 1015-1020. (Pubitemid 19265184)
249. Van der Neut, R.; Hol, E.M.; Gispen, W.H.; Bär, P.R. Stimulation by melanocortins of neurite outgrowth from spinal and sensory neurons in vitro. Peptides, 1992, 13, 1109-1115. (Pubitemid 23010903)
250. Bär, P.R.; Hol, E.M.; Gispen, W.H. Trophic effects of melanocortins on neuronal cells in culture. Ann. N.Y. Acad. Sci., 1993, 692, 284-286. (Pubitemid 23299546)
251. Adan, R.A.; van der Kraan, M.; Doornbos, R.P.; Bär, P.R.; Burbach, J.P.; Gispen, W.H. Melanocortin receptors mediate alpha-MSH-induced stimulation of neurite outgrowth in neuro 2A cells. Brain. Res. Mol. Brain. Res., 1996, 36, 37-44. (Pubitemid 26060732)
252. Silman, R.E.; Chard, T.; Lowry, P.J.; Smith, I.; Young, I. Human fetal pituitary peptides and parturition. Nature, 1976, 260, 716-717.
253. Swaab, D.F.; Visser, M. A function for alpha-MSH in fetal development and the presence of an alpha-MSH-like compound in nervous tissue. Front. Hormone Res., 1977, 4, 170-180.
254. Swaab, D.F.; Visser, M.; Tilders, F.J. Stimulation of intra-uterine growth in rat by alpha-melanocyte-stimulating hormone. J. Endocrinol., 1976, 70, 445-455.
255. Beckwith, B.E.; O'Quin, R.K.; Petro, M.S.; Kastin, A.J. The effects of neonatal injection of alpha-MSH on the open-field behavior of juvenile and adult rats. Physiol. Psychol., 1977, 5, 295-302.
256. Landfield, P.W.; Baskin, R.K.; Pitler, T.A. Brain aging correlates: retardation by hormonal-pharmacological treatments. Science, 1981, 214, 581-584. (Pubitemid 12206162)
257. Forslin Aronsson, A.; Spulber, S.; Oprica, M.; Winblad, B.; Post, C.; Schultzberg, M. Alpha-MSH rescues neurons from excitotoxic cell death. J. Mol. Neurosci., 2007, 33, 239-251. (Pubitemid 350242533)
258. Zanoli, P.; Benelli, A.; Bertolini. A. Improved recovery of nigro-striatally hemitransected rats induced by (Nle4-DPhe7)alpha-MSH: A central effect. Neuropeptides, 1988, 11, 137-142. (Pubitemid 18095030)
259. Elder, G.A.; De Gasperi, R.; Gama Sosa, M.A. Research update: neurogenesis in adult brain and neuropsychiatric disorders. Mt. Sinai J. Med., 2006, 73, 931-940. (Pubitemid 46040390)
260. Bitto, A.; Polito, F.; Irrera, N.; Calo, M.; Spaccapelo, L.; Marini, H.R.; Giuliani D.; Ottani, A.; Rinaldi, M.; Minutoli, L.; Guarini, S.; Squadrito, F.; Altavilla, D. Protective effects of melanocortins on short-Term changes in a rat model of traumatic brain injury. Critical Care Med., 2012, 40, 945-951.
261. Magnoni, S.; Stecchetti, N.; Colombo, G.; Carlin, A.; Colombo, A.; Lipton, J.M. et al. Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. J. Neurotrauma, 2003, 20, 251-260. (Pubitemid 36373822)
262. Agapova, T.Y.; Agniullin, Y.V.; Shadrina, M.I.; Shram, S.I.; Slominsky, P.A.; Lymborska, S.A.; Myasoedov, N.F. Neurotrophin gene expression in rat brain under the action of Semax, an analog of ACTH 4-10. Neurosci. Lett., 2007, 417, 201-205. (Pubitemid 46551357)
263. Giuliani, D.; Zaffe, D.; Ottani, A.; Spaccapelo, L.; Galantucci, M.; Minutoli, L.; Bitto, A.; Irrera, N.; Contri, M.; Altavilla, D.; Botticelli, A.R.; Squadrito, F.; Guarini, S. Treatment of cerebral ischemia with melanocortins acting at MC(4) receptors induces marked neurogenesis and long-lasting functional recovery. Acta Neuropathologica, 2011, 122, 443-453.
264. Giuliani, D.; Ottani, A.; Minatoli, L.; Di Stefano, V.; Galantucci, M.; Bitto A.; Zaffe, D.; Altavilla, D.; Botticelli, A. R.; Squadrito, F.; Guarini, S. Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268. Brain Behavior Imm., 2009, 23, 844-850.
265. Davis, S.; Bozon, B.; Laroche, S. How necessary is the activation of the immediate early gene zif268 in sinaptic plasticity and learning? Behav. Brain Res., 2003, 142, 17-30. (Pubitemid 36677587)
266. Hwang, I.K.; Yoo, K.Y.; Park, J.K.; Nam, Y.S.; Lee, I.S.; Kang, J.H.; Choi, S.Y.; Lee, J.Y.; Kang, T.C.; Won, M.H. Ischemia-related changes of adrenocorticotropic hormone immunoreactivity and its protective effect in the gerbil hippocampus after transient forebrain ischemia. Neuroscience, 2004, 126, 871-877. (Pubitemid 38780892)
267. Caruso, C.; Carniglia, L.; Durand, D.; Gonzalez, P.V.; Scimonelli, T.N.; Lasaga, M. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway. Mol. Cell Endocrinol., 2012, 348, 47-54.
268. Bijlsma, W.A.; Jennekens, F.G.; Schotman, P.; Gispen, W.H. Stimulation by ACTH(4-10) of nerve fiber regeneration following sciatic nerve crush. Muscle Nerve, 1983, 6, 104-12. (Pubitemid 13092079)
269. Edwards, P.M.; Van der Zee, C.E.; Verhaagen, J.; Schotman, P.; Jennekens, F.G.; Gispen, W.H. Evidence that the neurotrophic actions of alpha-MSH may derive from its ability to mimick the actions of a peptide formed in degenerating nerve stumps. J. Neurol. Sci., 1984, 64, 333-340. (Pubitemid 14118947)
270. Verhaagen, J.; Edwards, P.M.; Jennekens, F.G.; Schotman, P.; Gispen, W.H. Early effect of an ACTH(4-9) analog (Org 2766) on regenerative sprouting demonstrated by the use of neurofilament-binding antibodies isolated from a serum raised by alpha-MSH immunization. Brain. Res., 1987, 404, 142-150. (Pubitemid 17021890)
271. Strand, F.L.; Rose, K.J.; King, J.A.; Segarra, A.C.; Zuccarelli, L.A. ACTH modulation of nerve development and regeneration. Prog. Neurobiol.,1989, 33, 45-85. (Pubitemid 19180230)
272. Strand, F.L.; Lee, S.J.; Lee, T.S.; Zuccarelli, L.A.; Antonawich, F.J.; Kume, J.; et al. Non-corticotropic ACTH peptides modulate nerve development and regeneration. Rev. Neurosci., 1993, 4, 321-363. (Pubitemid 24031178)
273. Strand, F.L.; Williams, K.A.; Alves, S.E.; Antonawich, F.J.; Lee, T.S.; Lee, S.J.; et al. Melanocortins as factors in somatic neuromuscular growth and regrowth. Pharmacol. Ther., 1994, 62, 1-27. (Pubitemid 24234855)
274. Antonawich, F.J.; Azmitia, E.C.; Kramer, H.K.; Strand, F.L. Specificity versus redundancy of melanocortins in nerve regeneration. Ann. N.Y. Acad. Sci., 1994, 739, 60-73.
275. Hol, E.M., Sodaar, P., Bär, P.R. Dorsal root ganglia as an in vitro model for melanocortin-induced neuritogenesis. Pharmacological and mechanistic aspects. Ann. N.Y. Acad. Sci., 1994, 739, 74-86.
276. Lankhorst, A.J.; ter Laak, M.P.; Hamers, F.P.; Gispen, W.H. Combined treatment with alphaMSH and methylprednisolone fails to improve functional recovery after spinal injury in the rat. Brain. Res., 2000, 859, 334-340. (Pubitemid 30136106)
277. Van der Kraan, M.; Tatro, J.B.; Entwistle, M.L.; Brakkee, J.H.; Burbach, J.P.; Adan, R.A.; et al. Expression of melanocortin receptors and proopiomelanocortin in the rat spinal cord in relation to neurotrophic effects ofmelanocortins. Brain. Res. Mol. 1999, 63, 276-286. (Pubitemid 29036979)
278. Ter Laak, M.P.; Brakkee, J.H.; Adan, R.A.; Hamers, F.P.; Gispen, W.H. The potent melanocortin receptor agonist melanotan-II promotes peripheral nerve regeneration and has neuroprotective properties in the rat. Eur. J. Pharmacol., 2003, 462, 179-183. (Pubitemid 36187421)
279. Van der Zee, C.E.; Van der Hoop, R.G.; Gispen, W.H. Beneficial effect of Org 2766 in treatment of peripheral neuropathy in streptozocin-induced diabetic rats. Diabetes, 1989, 38, 225-230. (Pubitemid 19054805)
280. Bravenboer, B.; Kappelle, A.C.; van Buren, T.; Erkelens, D.W.; Gispen, W.H. ACTH4-9 analog ORG 2766 can improve existing neuropathy in streptozotocin induced diabetic rats. Acta Diabetol., 1993, 30, 21-24. (Pubitemid 23286363)
281. Gerritsen van der Hoop, R.; de Koning, P.; Boven, E.; Neijt, J.P.; Jennekens, F.G.; Gispen, W.H. Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in rats. Eur. J. Cancer. Clin. Oncol., 1988, 24, 637-642. (Pubitemid 18095567)
282. Gerritsen van der Hoop, R.; Hamers, F.P.; Neijt, J.P.; Veldman, H.; Gispen, W.H.; Jennekens, F.G. Protection against cisplatin-induced neurotoxicity by ORG.2766. Histological and electrophysiological evidence. J. Neurol. Sci., 1994, 126, 109-115. (Pubitemid 24329765)
283. de Koning, P.; Neijt, J.P.; Jennekens, F.G.; Gispen, W.H. ORG 2766 protects from cisplatin-induced neurotoxicity in rats. Exp. Neurol., 1987, 97, 746-750. (Pubitemid 17143125)
284. Gandara, D.R.; Perez, E.A.; Weibe, V.; De Gregorio, M.W. Cisplatin chemoprotection and rescue: pharmacologic modulation of toxicity. Semin. Oncol., 1991,18, 49-55.
285. Gispen, W.H.; Hamers, F.P.; Vecht, C.J.; Jennekens, F.G.; Neyt, J.P. ACTH/MSH like peptides in the treatment of cisplatin neuropathy. J. Steroid Biochem. Mol. Biol., 1992, 43, 179-183.
286. Hamers, F.; Neijt, J.; Gispen, W. protection of cisplatin-induced neuropathy: recent developments. Pathol. Biol., 1992, 39, 829-830.
287. Hamers, F.P.; Pette, C.; Bravenboer, B.; Vecht, C.J.; Neijt, J.P.; Gispen, W.H. Cisplatin induced neuropathy in mature rats: effects of the melanocortin-derived peptide ORG 2766. Cancer Chemother. Pharmacol., 1993, 32, 162-166. (Pubitemid 23131938)
288. Bruinink, A.; Birchler, F. Effects of cisplatin and ORG 2766 in chick embryonic brain cell cultures. Arch. Toxicol., 1993, 67, 325-329. (Pubitemid 23180978)
289. Cavaletti, G.; Cascinu, S.; Venturino, P.; Tedeschi, M.; Tredici, G. Neuroprotectant drugs in cisplatin neurotoxicity. Anticancer Res., 1996, 16, 3149-3159. (Pubitemid 26390264)
290. Heijmen, P.S.; Klis, S.F.; De Groot, J.C.; Smoorenburg, G.F. Cisplatin ototoxicity and the possibly protective effect of alpha-melanocyte stimulating hormone. Hear Res., 1999, 128, 27-39. (Pubitemid 29083242)
291. Van der Hoop, R.G.; Vecht, C.J.; van der Burg, M.E.; Elderson, A.; Boogerd, W.; Heimans, J.J. Prevention of cisplatin neurotoxicity with an ACTH(4-9) analog in patients with ovarian cancer. N. Engl. J. Med., 1990, 322, 89-94. (Pubitemid 20023866)
292. Gispen, W.H. Therapeutic potential for melanocortins in peripheral nerve disease. Trends Pharmacol. Sci., 1990, 11, 221-222. (Pubitemid 20175411)
293. Van Gerven, J.M.; Hovestadt, A.; Moll, J.W.; Rodenburg, C.J.; Splinter, T.A.; van Oosterom, A.T. The effects of an ACTH (4-9) analog on development of cisplatinneuropathy in testicular cancer: A randomized trial. J. Neurol., 1994, 241, 432-435. (Pubitemid 24194067)
294. Albers, I.W.; Chaudhry, V.; Cavaletti, G.; Donehower, R.C. Interventions for preventing neuropathy caused by cisplatin and related compounds. Cochrane Database Syst. Rev. 2011, 2, CD005228.
295. Hamers, F.P.; Pette, C.; Neijt, J.P.; Gispen, W.H. The ACTH-(4-9) analog, ORG2766, prevents taxol-induced neuropathy in rats. Eur. J. Pharmacol., 1993, 233, 177-178. (Pubitemid 23091762)
296. Facchinetti, F.; Nappi, G.; Petraglia, F.; Martignoni, E.; Sinforiani, E.; Genazzani, A.R. Central ACTH deficit in degenerative and vascular dementia. Life Sci., 1984, 35,1691-1697. (Pubitemid 14031999)
297. Anderson, B. Is alpha-MSH deficiency the cause of Alzheimer's disease? Med. Hypotheses, 1986, 19, 379-385. (Pubitemid 16136195)
298. Rainero, I.; Kaye, I.A.; May, C.; Durso, R.; Katz, D.I.; Albert, M.L.; Wolfe, N.; Pinessi, L.; Friedland, R.P.; Rapoport, S.I. Alpha-melanocyte- stimulating hormone like immunoreactivity is increased in cerebrospinalfluid of patients with Parkinson's disease. Arch. Neurol., 1988, 45, 1224-1227.
299. Wood, P.L.; Malthe-Sorenssen, D.; Cheney, D.L.; Costa, E. Increase of hippocampal acetylcholine turnover rate and the stretching-yawning syndrome elicited by alpha-MSH and ACTH. Life Sci., 1978, 22, 673-678. (Pubitemid 8305000)
300. Matsumoto, T.; Tsuda, S.; Nakamura, S. The neurotrophic effect of ebirtide, an analog of ACTH4-9, on cultured septal cells and aged rats. J. Neural. Transm. Gen. Sect., 1995, 100, 1-15.
301. Costa, A.; Bini, P.; Hamze-Sinno, M.; Moglia, A.; Franciotta, D.; Sinforiani, E.; Ravaglia, S.; Bole Feysot, C.; Hökfelt, T.; Déchelotte, P.; Fetissov, S.O. Galanin and -MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. J. Neuroimmunol., 2011, 240-241, 114-120.
302. Bertolini, A.; Baggio, G.; Ferrari, F.; Poggioli, R.; Fratta, W. Peptidi ACTHsimili e peptidi oppioidi: un probabile sistema omeostatico modulante
303. Dunn, A.J.; Iuvone, P.M.; Rees, H.D. Neurochemical responses of mice to ACTH and lysine vasopressin. Pharmacol. Biochem. Behav., 1976, 5, 139-145.
304. Lichtensteiger, W.; Lienhart, R. Response of mesencephalic and hypothalamic dopamine neurones to alpha-MSH: mediated by area postrema? Nature, 1977, 266, 635-637. (Pubitemid 8068503)
305. Iuvone, P.M.; Morasco, J.; Delanoy, R.L.; Dun, A.J. Peptides and the conversion of [3H]tyrosine to catecholamines: effects of ACTH-Analogs, melanocyte stimulating hormones and lysine-vasopressin. Brain Res., 1978, 139, 131-139. (Pubitemid 8237241)
306. Wiegant, V.M.; Cools, A.R.; Gispen, WH. ACTH-induced excessive grooming involving brain dopamine.. Eur. J. Pharmacol., 1977, 41, 343-347.
307. Cools, A.R.; Wiegant, V.M.; Gispen, W.H. Distinct dopaminergic systems in ACTH-induced grooming. Eur. J. Pharmacol., 1978, 50, 265-273.
308. Baraldi, M.; Benassi Benelli, A. Dissociation of the capacity of apomorphine to evoke penile erection and stereotypy following intragastric administration to adult rats. Riv. Farmacol. Terap., 1975, 6, 361-366.
309. Heusner, A.P. Yawning and associated phenomena. Physiol. Rev., 1946, 26, 156-188.
310. Halabe Bucay A. Activation of the proopiomelanocortin gene with ketoconazole as a treatment for Parkinson's disease: A new hypothesis. Ann. N.Y. Acad. Sci., 2008, 1144, 237-242. 0.